August 26, 2015

Genetic Mutation Analysis May Improve Treatment in Multiple Myeloma

Testing for genetic risk factors may improve myeloma treatments by identifying those at risk for more aggressive disease. This study, published in the Journal of Clinicial Oncology and led by researchers in London, including our own Myeloma Center Director, Dr. Gareth Morgan, is the first to link genetic mutations in myeloma cells to the chances of surviving the disease.

Read more:
http://www.targetedonc.com/news/genetic-mutation-analysis-may-improve-treatment-in-multiple-myeloma